Table 1.
Characteristics of study participants
| Patient | Age | Sex | GMFCS | Pop Angle | Limbs | Prev Surg | BTX | Baclofen |
|---|---|---|---|---|---|---|---|---|
| CP1 | 9 | M | 5 | 110 | Q | No | No | Yes |
| CP2 | 7 | M | 2 | 100 | D | No | Yes | No |
| CP3 | 8 | M | 2 | 100 | D | No | Yes | No |
| CP4 | 3 | M | 4 | 110 | Q | No | Yes | Yes |
| CP5 | 18 | F | 5 | 100 | Q | Yes | No | Yes |
| CP6 | 8 | F | 3 | 110 | D | No | Yes | Yes |
| CP7 | 10 | M | 4 | 135 | Q | Yes | Yes | Yes |
| CP8 | 8 | F | 3 | 120 | D | No | Yes | No |
| TD1 | 16 | M | NA | NA | NA | No | No | No |
| TD2 | 15 | M | NA | NA | NA | No | No | No |
| TD3 | 15 | M | NA | NA | NA | No | No | No |
| TD4 | 14 | F | NA | NA | NA | No | No | No |
| TD5 | 16 | F | NA | NA | NA | No | No | No |
| TD6 | 15 | M | NA | NA | NA | No | No | No |
| TD7 | 14 | F | NA | NA | NA | No | No | No |
| TD8 | 18 | F | NA | NA | NA | No | No | No |
Baclofen, whether patient had exposure to baclofen (>6 mo prior); BTX, whether patient had exposure to botulinum toxin (>6 mo prior); CP, cerebral palsy; D, diplegia; F, female; GMFCS, Gross Motor Function Classification System; M, male; NA, nonapplicable; Pop, popliteal; Prev surg, whether the patient had previous surgeries (>6 mo prior); Q, quadriplegia; TD, typically developing. Age measured in years; popliteal angle measured in degrees.